Naringenin Ameliorates Hyperuricemia by Regulating Renal Uric Acid Excretion via the PI3K/AKT Signaling Pathway and Renal Inflammation through the NF-κB Signaling Pathway
Journal of Agricultural and Food Chemistry · 25.01.2023 · 71 (3) · 1434-1446
DOI: 10.1021/acs.jafc.2c01513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 16.12.2022. Verfasst von Bendong Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Research, School of Life Sciences and Medicine, Shandong University of Technology, Zibo, Shandong 255000, People's Republic o…. Hauptthemen laut MEDLINE: Hyperuricemia. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Taishan Scholar Project of Shandong Province, Major Scientific and Technological Innovation Project of Shandong Province.
Abstract (Originalsprache)
Hyperuricemia characterized by high serum levels of uric acid (UA, >6.8 mg/dL) is regarded as a common chronic metabolic disease. When used as a food supplement, naringenin might have various pharmacological activities, including antioxidant, free-radical-scavenging, and inflammation-suppressing activities. However, the effects of naringenin on hyperuricemia and renal inflammation and the underlying mechanisms remain to be elucidated. Here, we comprehensively examined the effects of naringenin on hyperuricemia and the attenuation of renal impairment. Mice were injected with 250 mg/kg of potassium oxonate (PO) and given 5% fructose water to induce hyperuricemia. The pharmacological effects of naringenin (10 and 50 mg/kg) and benzbromarone (positive control group, 20 mg/kg) on hyperuricemic mice were evaluated in vivo. The disordered expression of urate transporters in HK-2 cells was stimulated by 8 mg/dL UA, which was used to determine the mechanisms underlying the effects of naringenin in vitro. Naringenin markedly reduced the serum UA level in a dose-dependent manner and improved renal dysfunction. Moreover, the increased elimination of UA in urine showed that the effects of naringenin were associated with the regulation of renal excretion. Further examination indicated that naringenin reduced the expression of GLUT9 by inhibiting the PI3K/AKT signaling pathway and reinforced the expression of ABCG2 by increasing the abundance of PDZK1 in vivo and in vitro. Furthermore, sirius red staining and western blotting indicated that naringenin plays a protective role in renal injury by suppressing increases in the levels of pro-inflammatory cytokines, including IL-6 and TNF-α, which contribute to the inhibition of the TLR4/NF-κB signaling pathway in vivo and in vitro. Naringenin supplementation might be a potential therapeutic strategy to ameliorate hyperuricemia by promoting UA excretion in the kidney and attenuating the inflammatory response by decreasing the release of inflammatory cytokines. This study shows that naringenin could be used as a functional food or dietary supplement for hyperuricemia prevention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Research, School of Life Sciences and Medicine, Shandong University of Technology, Zibo, Shandong 255000, People's Republic of China.
- College of Life Science, Yangtze University, Jingzhou, Hubei 434100, People's Republic of China.
- Key Laboratory of Novel Food Resources Processing, Ministry of Agriculture and Rural Affairs/Key Laboratory of Agro-Products Processing Technology of Shandong Province/Institute of Agro-Food Science and Technology, Shan…
- Shandong Qingyujiangxing Biotechnology Company, Limited, Zibo, Shandong 255000, People's Republic of China.
- School of Public Health and Management, Weifang Medical University, 7166 Baotong Road, Weifang, Shandong 261053, People's Republic of China.
ORCID-Profile: Bendong Yang, Chao Liu, Wenlong Sun
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Taishan Scholar Project of Shandong Province
- Major Scientific and Technological Innovation Project of Shandong Province
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Innovation Ability Improvement Project of Science and Technology SMEs in Shandong Province
- Zhangdian School-City Integrated Development Project
Zitieren
APA
Yang, B., Xin, M., Liang, S., Huang, Y., Li, J., Wang, C., Liu, C., Song, X., Sun, J., & Sun, W. (2023). Naringenin Ameliorates Hyperuricemia by Regulating Renal Uric Acid Excretion via the PI3K/AKT Signaling Pathway and Renal Inflammation through the NF-κB Signaling Pathway. Journal of Agricultural and Food Chemistry, 71(3), 1434-1446. https://doi.org/10.1021/acs.jafc.2c01513
Vancouver
Yang B, Xin M, Liang S, Huang Y, Li J, Wang C, et al. Naringenin Ameliorates Hyperuricemia by Regulating Renal Uric Acid Excretion via the PI3K/AKT Signaling Pathway and Renal Inflammation through the NF-κB Signaling Pathway. Journal of Agricultural and Food Chemistry. 2023;71(3):1434-1446. doi:10.1021/acs.jafc.2c01513
BibTeX
@article{Yang2023,
author = {Yang, Bendong and Xin, Meiling and Liang, Shufei and Huang, Yuhong and Li, Jingda and Wang, Chao and Liu, Chao and Song, Xinhua and Sun, Jinyue and Sun, Wenlong},
title = {Naringenin Ameliorates Hyperuricemia by Regulating Renal Uric Acid Excretion via the PI3K/AKT Signaling Pathway and Renal Inflammation through the NF-κB Signaling Pathway},
journal = {Journal of Agricultural and Food Chemistry},
year = {2023},
volume = {71},
number = {3},
pages = {1434--1446},
doi = {10.1021/acs.jafc.2c01513}
}
EUVIMED